Abstract
Introduction The damaged articular cartilage has limited self-regeneration capacity because of the absence of blood vessels, lymphatics, and nerves. Cartilage transplantation is, hence, a popular method used to treat this disease. However, sources of autograft and allogenic cartilage for transplantation are limited. Therefore, this study aims to suggest a simple method to produce engineered cartilage from human adipose-derived mesenchymal stem cells (ADSCs) and poly (ε-caprolactone) (PCL) scaffolds.
Methods ADSCs were isolated and expanded from fat tissues according to published protocols. PCL-porous scaffolds were produced from PCL with 5 × 5 × 0.6 mm3 with 200–400 μ m pore sizes. ADSCs were seeded on the PCL scaffolds at three different densities (104, 105, 106 cells per scaffold). The adherence of ADSCs on the surface of PCL scaffolds was evaluated based on an immunostaining assay to determine the presence of ADSCs. The cell proliferation on PCL scaffolds was determined by MTT assay. The complexity in ADSCs and PCL scaffolds was induced to cartilage using a chondrogenesis medium. The engineered cartilage was characterized by the accumulation of proteoglycan and aggrecan by Safranin O staining assay. Their structures were evaluated using an H-E staining assay. Finally, these engineered cartilage tissues were transplanted into mice to assess cartilage maturation when compared to natural cartilage.
Results The results showed that the engineered cartilage tissues could be successfully produced by cultures of ADSCs on poly ε-caprolactone scaffolds in combination with chondrogenesis medium. The suitable density of ADSCs was 106 cells/per scaffold of 5 × 6 × 0.6 mm3 with pore size from 200 to 400 μ m.
Conclusion The results showed that an in vitro cartilage tissue was created from ADSCs and PCL scaffold. The cartilage tissue exists in the mice for 6 months.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADSC:
-
Adipose-derived stem cells
- CD:
-
Cluster of differentiation
- ECM:
-
Extracellular matrix
- MSC:
-
Mesenchymal stem cell
- PBS:
-
Phosphate buffer saline
- PCL:
-
Poly (ε-caprolactone)
References
Alaribe Franca, N., Manoto Sello, L., & Motaung Shirley, C. K. M. (2016). Scaffolds from biomaterials: advantages and limitations in bone and tissue engineering. Biologia, 353.
Aleksandra, H., Magda, M., & Anita, B.-J. (2017). Biodegradation of poly(ε-caprolactone) in natural water environments. Polish Journal of Chemical Technology, 19(1), 120–126.
Bacakova, L., et al. (2004). Cell adhesion on artificial materials for tissue engineering. Physiological Research, 53(Suppl 1), S35–S45.
Bayliss, L. E., et al. (2017). The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet (London, England), 389(10077), 1424–1430.
Choong, C., Triffitt, J. T., & Cui, Z. F. (2004). Polycaprolactone scaffolds for bone tissue engineering: Effects of a calcium phosphate coating layer on osteogenic cells. Food and Bioproducts Processing, 82(2), 117–125.
Chung, C., & Burdick, J. A. (2008). Engineering cartilage tissue. Advanced Drug Delivery Reviews, 60(2), 243–262.
Colnot, C. (2011). Cell sources for bone tissue engineering: Insights from basic science. Tissue Engineering. Part B, Reviews, 17(6), 449–457.
Danisovic, L., Varga, I., & Polak, S. (2012). Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue & Cell, 44(2), 69–73.
de Isla, N., et al. (2010). Introduction to tissue engineering and application for cartilage engineering. Bio-medical Materials and Engineering, 20(3), 127–133.
Dominici, M., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317.
Frydrych, M., et al. (2015). Biomimetic poly(glycerol sebacate)/poly(l-lactic acid) blend scaffolds for adipose tissue engineering. Acta Biomaterialia, 18, 40–49.
Fu, W., et al. (2014). Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering. International Journal of Nanomedicine, 9, 2335–2344.
Groth, T., et al. (1999). Altered vitronectin receptor (αv integrin) function in fibroblasts adhering on hydrophobic glass. Journal of Biomedical Materials Research, 44(3), 341–351.
Hall, B. K. (2015). Chapter 4: Invertebrate cartilages, notochordal cartilage and cartilage origins. In B. K. Hall (Ed.), Bones and cartilage (2nd ed., pp. 63–78). San Diego: Academic.
He, Y., & Lu, F. (2016). Development of synthetic and natural materials for tissue engineering applications using adipose stem cells. Stem Cells International, 2016, 12.
Hoemann, C. D., et al. (2012). The cartilage-bone interface. The Journal of Knee Surgery, 25(2), 85–97.
Hubbell, J. A. (2003). Materials as morphogenetic guides in tissue engineering. Current Opinion in Biotechnology, 14(5), 551–558.
Iwamoto, M., et al. (2013). Toward regeneration of articular cartilage. Birth defects research. Part C, Embryo Today: Reviews, 99(3), 192–202.
Kawakami, Y., Rodriguez-Leon, J., & Izpisua Belmonte, J. C. (2006). The role of TGFbetas and Sox9 during limb chondrogenesis. Current Opinion in Cell Biology, 18(6), 723–729.
Khademhosseini, A., et al. (2014). Chapter 32: Embryonic stem cells as a cell source for tissue engineering. In R. Lanza, R. Langer, & J. Vacanti (Eds.), Principles of tissue engineering (4th ed., pp. 609–638). Boston: Academic.
Machado, C. d. V, Telles, P. D. d. S, & Nascimento, I. L. O. (2013). Immunological characteristics of mesenchymal stem cells. Revista Brasileira de Hematologia e Hemoterapia, 35(1), 62–67.
Mano, J. F., et al. (2007). Natural origin biodegradable systems in tissue engineering and regenerative medicine: Present status and some moving trends. Journal of the Royal Society, Interface, 4(17), 999–1030.
Middleton, J. C., & Tipton, A. J. (2000). Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 21(23), 2335–2346.
Miljkovic, N. D., Cooper, G. M., & Marra, K. G. (2008). Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis and Cartilage, 16(10), 1121–1130.
Mondal, D., Griffith, M., & Venkatraman, S. S. (2016). Polycaprolactone-based biomaterials for tissue engineering and drug delivery: Current scenario and challenges. International Journal of Polymeric Materials and Polymeric Biomaterials, 65(5), 255–265.
Murphy, C. M., et al. (2013). Cell-scaffold interactions in the bone tissue engineering triad. European Cells & Materials, 26, 120–132.
Oh, S. H., et al. (2007). In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials, 28(9), 1664–1671.
Oldershaw, R. A. (2012). Cell sources for the regeneration of articular cartilage: The past, the horizon and the future. International Journal of Experimental Pathology, 93(6), 389–400.
Pisanu, G., et al. (2018). Large osteochondral allografts of the knee: Surgical technique and indications. Joints, 6(1), 42–53.
Sophia Fox, A. J., Bedi, A., & Rodeo, S. A. (2009). The basic science of articular cartilage: Structure, composition, and function. Sports Health, 1(6), 461–468.
Tabata, Y., et al. (2000). De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Engineering, 6(3), 279–289.
Tang, L., Wu, Y., & Timmons, R. B. (1998). Fibrinogen adsorption and host tissue responses to plasma functionalized surfaces. Journal of Biomedical Materials Research, 42(1), 156–163.
Toonstra, J. L., et al. (2016). Patient experiences of recovery after autologous chondrocyte implantation: A qualitative study. Journal of Athletic Training, 51(12), 1028–1036.
Truong, N. C., Bui, K. H.-T., & Van Pham, P. (2018). Characterization of senescence of human adipose-derived stem cells after long-term expansion. In Tissue engineering and regenerative medicine (pp. 109–128). Springer.
Tuan, R. S., Chen, A. F., & Klatt, B. A. (2013a). Cartilage regeneration. The Journal of the American Academy of Orthopaedic Surgeons, 21(5), 303–311.
Tuan, R. S., Chen, A. F., & Klatt, B. A. (2013b). Cartilage regeneration. The Journal of the American Academy of Orthopaedic Surgeons, 21(5), 303–311.
Tuzlakoglu, K., et al. (2004). Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. Macromolecular Bioscience, 4(8), 811–819.
Valcourt, U., et al. (1999). Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Experimental Cell Research, 251(2), 264–274.
Van Pham, P., et al. (2014). Good manufacturing practice-compliant isolation and culture of human adipose-derived stem cells. Biomedical Research and Therapy, 1(04), 133–141.
Vinatier, C., & Guicheux, J. (2016). Cartilage tissue engineering: From biomaterials and stem cells to osteoarthritis treatments. Annals of Physical and Rehabilitation Medicine, 59(3), 139–144.
Vinatier, C., et al. (2009). Cartilage engineering: A crucial combination of cells, biomaterials and biofactors. Trends in Biotechnology, 27(5), 307–314.
Wall, A., & Board, T. (2014). Chemical basis for the histological use of Safranin O in the study of articular cartilage. In P. A. Banaszkiewicz & D. F. Kader (Eds.), Classic papers in orthopaedics (pp. 433–435). London: Springer.
Woodruff, M. A., & Hutmacher, D. W. (2010). The return of a forgotten polymer—Polycaprolactone in the 21st century. Progress in Polymer Science, 35(10), 1217–1256.
Acknowledgements
This research is funded by Vietnam National University Ho Chi Minh City (VNU-HCM) under grant number C2017-18-24/HĐ-KHCN.
Conflict of Interest
The authors declare that there is no conflict of interest regarding the publication of this paper.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Nguyen, H.TN., Vu, N.B. (2021). A Simple Method to Produce Engineered Cartilage from Human Adipose-Derived Mesenchymal Stem Cells and Poly ε-Caprolactone Scaffolds. In: Pham, P.V. (eds) Advances in Mesenchymal Stem Cells and Tissue Engineering. ICRRM 2023. Advances in Experimental Medicine and Biology(). Springer, Cham. https://doi.org/10.1007/5584_2021_669
Download citation
DOI: https://doi.org/10.1007/5584_2021_669
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-38612-1
Online ISBN: 978-3-031-38613-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)